Ligand validation:6LZY

EDO: 1,2-ETHANEDIOL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6LZY_EDO_B_509	47%	98%	0.131	0.87	0.1	0.17	-	-	0	0	100%	1
6LZY_EDO_B_511	40%	91%	0.168	0.88	0.13	0.42	-	-	3	0	100%	1
6LZY_EDO_B_508	34%	99%	0.198	0.883	0.05	0.18	-	-	0	0	100%	1
6LZY_EDO_B_503	34%	90%	0.232	0.918	0.18	0.41	-	-	0	0	100%	1
6LZY_EDO_B_506	27%	96%	0.243	0.892	0.09	0.25	-	-	0	0	100%	1
6LZY_EDO_B_504	13%	79%	0.244	0.788	0.33	0.54	-	-	1	0	100%	1
6LZY_EDO_B_505	11%	89%	0.273	0.785	0.22	0.42	-	-	0	0	100%	1
6LZY_EDO_B_510	9%	69%	0.328	0.823	0.5	0.7	-	-	2	0	100%	1
6LZY_EDO_B_507	9%	94%	0.258	0.743	0.15	0.29	-	-	0	0	100%	1
6LZY_EDO_A_604	8%	76%	0.272	0.741	0.39	0.54	-	-	0	0	100%	1
6LZY_EDO_A_606	3%	87%	0.306	0.66	0.29	0.4	-	-	1	0	100%	1
6LZY_EDO_A_605	3%	85%	0.341	0.692	0.37	0.38	-	-	0	0	100%	1
6LZY_EDO_A_603	2%	92%	0.356	0.646	0.19	0.32	-	-	0	0	100%	1
7VEJ_EDO_B_601	24%	78%	0.154	0.78	0.54	0.35	-	-	0	0	100%	1
6ANS_EDO_A_404	100%	89%	0.029	0.995	0.57	0.07	-	-	0	0	100%	1
4ITB_EDO_A_503	100%	88%	0.028	0.99	0.38	0.29	-	-	0	0	100%	1
4FQI_EDO_A_401	100%	85%	0.032	0.992	0.46	0.29	-	-	0	0	100%	1
4KXW_EDO_A_1003	100%	73%	0.033	0.993	0.64	0.4	-	-	0	0	100%	1
8JK3_EDO_A_304	100%	81%	0.033	0.992	0.22	0.58	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.